期刊文献+

血栓抽吸导管对小血栓负荷急性心肌梗死患者介入治疗的影响 被引量:2

Effect of thrombus aspiration catheter during primary percutaneous coronary intervention on acute myocardial infarction patients with small thrombosis burden
下载PDF
导出
摘要 目的探讨血栓抽吸导管对小血栓负荷的急性心肌梗死患者直接经皮冠状动脉介入治疗(PCI)后心肌组织水平灌注和临床预后的影响。方法连续入选小血栓负荷的急性心肌梗死患者83例。随机分为治疗组(36例)经冠状动脉内血栓抽吸导管抽吸后植入支架;对照组(47例)标准支架植入术。比较两组患者临床基线资料、术后冠状动脉造影结果、心电图、心功能变化及随访期间主要不良心血管事件情况。结果两组患者的基线临床资料差异均无统计学意义(P均〉0.05)。对照组患者1例术后出现慢血流,其余患者术后心肌梗死溶栓试验(TIMI)血流均达到3级;治疗组均达到TIMI血流3级,但两组相比未达到统计学差异。两组患者术后2h ST段回降程度、术后5-7d左心室射血分数及术后12个月主要不良心脏事件发生率差异均无统计学意义。结论血栓抽吸导管对小血栓负荷急性心肌梗死患者行直接PCI时未能获得更多的益处。 Objective To explore the impact of thrombus aspiration catheter on myocardial reperfusion and major adverse cardiovascular events rate in acute myocardial infarction patients with small thrombosis burden. Methods Eighty –three consecutive acute myocardial infarction patients with small thrombosis burden were randomly assigned to thrombus aspiration group(n=36) and standard stent implantation group(n=47) with random number table.Baseline clinical data,angiographic features, electrocardiogram, heart function and major adverse cardiovascular events after PCI between 2 groups were compared. compared.Results The baseline clinical data between 2 groups was similar(all P〉0.05). One patients had slow flow in standard stent implantation group, the remaining patients with TIMI 3 flow were achieved in 2 groups. ST-segment elevation reduction at 2 hours, left ventricular ejection fraction at 5-7 days and the incidence of major adverse cardiovascular events at 12 months after PCI showed no significant differences. Conclusion Thrombus aspiration catheter during primary percutaneous coronary intervention on acute myocardial infarction patients with small thrombosis burden failed to gain more benefits.
作者 刘新锋
出处 《中国医药科学》 2015年第2期169-171,共3页 China Medicine And Pharmacy
关键词 心肌梗死 血管成形术 经皮冠状动脉 Myocardial infarction Angioplasty Percutaneous coronary
  • 相关文献

参考文献12

  • 1Keeley E, Boura J, Grines C.Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction : a quantitative review of 23 randomised trials[J]. Lancet,2003,361 ( 9351 ) : 13-20.
  • 2潘港,徐细平,冯小坚,龙胜春,罗琼.DIVER CE血栓抽吸导管联合替罗非班在急诊冠状动脉介入治疗中的应用[J].中国循证心血管医学杂志,2011,3(3):186-188. 被引量:24
  • 3Ndrepepa G, Tiroch K, Keta D, et al.Predictive factors and impact of no-flow after primary percutaneous Coronaryintervention in patients with acute myocardial infarction[J]. Cirecardiovase Intervent, 2010,3 ( 1 ) : 27-33.
  • 4Ndrepepa G, Tiroch K, Fusaro M, et al.5-Year prognostic value of no-flow phenomenon after percutaneous Coronary intervention in patients with acute myocardial infarction[J]. AM Cool Cardiol, 2010, 55 ( 21 ) : 2383-2389.
  • 5Yunoki K, Naruko T, Sugioka K, et al.Thrombus Aspiration Therapy and CoronaryThrombus Components in Patients with Acute ST-Elevation Myocardial Infarction[J]. J Atheroscler Thromb, 2013,20 ( 6 ) : 524-537.
  • 6张大鹏,王乐丰,杜锦权,王红石,徐立,李惟铭,倪祝华,夏昆,刘宇,杨新春.经血栓抽吸导管注射替罗非班和硝普钠对重度血栓负荷前壁急性心肌梗死患者急诊介入治疗效果的影响[J].中华心血管病杂志,2014,42(1):25-30. 被引量:67
  • 7Yip HK, Chen MC, Chang HW, et al.Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow phenomenon[J].Chest, 2002,122 ( 4 ) : 1322-1332.
  • 8Hara M, Saikawa T, Tsunematsu Y, et al.Predicting no- reflow based on angiographic features of lesions in patients with acute myocardial infarction [J]. J Atheroscler Thromb, 2005,12 ( 6 ): 315-321.
  • 9Ito H. No-reflow phenomenon and prognosis in patients with acute myocardial infarction[J].Nat Clin Pract Cardiovasc Med, 2006,3 ( 9 ) : 499-506.
  • 10Valgimigli M, Campo G, Malagutti P, et al.Persistent coronary no flow after wire insertion is an early and readlily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the Strategy trials[J].JACC Cardiovasc Interv, 2011,4 ( 1 ): 51-62.

二级参考文献13

  • 1YAN Hong-bing WANG Jian LI Nan ZHU Xiao-ling GAO Hai AI Hui LI Xiang YE Ming CHI Yun-peng ZHANG Hong.Diver CE versus Guardwire Plus for thrombectomy in patients with inferior myocardial infarction:a trial of aspiration of thrombus during primary angioplasty for inferior myocardial infarction[J].Chinese Medical Journal,2007(7):557-561. 被引量:29
  • 2杨新春,张大鹏,王乐丰,徐立,葛永贵,王红石,李惟铭,倪祝华,夏昆,连勇,薛永利,马利祥.冠状动脉内应用国产替罗非班对急性ST段抬高心肌梗死急诊介入治疗后心肌灌注和临床预后的影响[J].中华心血管病杂志,2007,35(6):517-522. 被引量:73
  • 3Ito H, Okamura A, Iwakura K, et al.Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction[J].Circulation, 1996, 93: 1993-1999.
  • 4Tanaka A, Kawarabayashi T, Nishibori Y, et al.No-reflow phenomenon and lesion morphology in patients with acute myocardial infarction[J].Circulation, 2002, 105: 2148- 2152.
  • 5Yip HK, Chen MC, Chang HW, et al.Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow phenomenon[J].Chest, 2002, 122:1322-1332.
  • 6Hara M, Saikawa T, Tsunematsu Y, et al.Predicting no-reflow based on angiographic features of lesions in patients with acute myocardial infarction[J].J Atheroscler Thromb, 2005, 12:315-321.
  • 7Chesebro JH, Knatterud G, Roberts R, et al.Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase.Clinical findings through hospital discharge[J].Circulation, 1987, 76:142-154.
  • 8Gibson CM, Cannon CP, Murphy SA, et al.Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs[J].Circulation, 2000, 101:125-130.
  • 9O′Gara PT, Kushner FG, Ascheim DD,et al.2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J].J Am Coll Cardiol, 2013,61:e78-e140.
  • 10Hillegass WB, Dean NA, Liao L, et al.Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneous coronary interventions: initial human clinical experience[J].J Am Coll Cardiol, 2001, 37: 1335-1343.

共引文献86

同被引文献22

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部